Recently, the treasury strategy for Bitcoin (BTC), Ethereum (ETH), and altcoins has begun to accelerate. Companies are announcing multi-million dollar moves one after another, with the latest announcement coming from Mei Pharma. At this point, according to BWEnews, Nasdaq-listed MEI Pharma launched a Litecoin (LTC) treasury strategy worth $100 million. Mei Pharma's $100 million investment in LTC institutional investment suggests growing institutional interest in altcoins beyond Bitcoin. This raises the expectation that more firms will allocate a portion of their treasury reserves to cryptocurrencies and diversify their portfolios. This move by Mei Pharma stands as one of the largest institutional LTC acquisitions to date. This move follows similar treasury diversification moves by companies like MicroStrategy, Tesla, and Sharplink Gaming, but MEI Pharma stands out for its preference for Litecoin over more mainstream institutional options like Bitcoin and Etheruem. Litecoin, which has increased by 10% in the last 24 hours, has increased by 14% in the last week and 28% in the last month. *This is not investment advice. Continue Reading: This Altcoin Just Received Its Largest Institutional Investment Ever! Here Are the Details…
![Plasma [XPL] rockets 87% to ATH! Why this whale-backed rally is far from over](https://images.cryptocompare.com/news/default/ambcrypto.png "Plasma [XPL] rockets 87% to ATH! Why this whale-backed rally is far from over")
